Literature DB >> 11437895

Sleep disturbances after whiplash injury: objective and subjective findings.

I Schlesinger1, R Hering-Hanit, Y Dagan.   

Abstract

OBJECTIVE: A controlled objective and subjective evaluation of sleep in a consecutive series of persons who had had a whiplash injury, shortly following the injury and 3 to 5 months later.
METHODS: In whiplash-injured subjects and healthy controls, sleep characteristics were monitored objectively throughout the night by means of an actigraph. The following morning, participants in both groups filled out a prestructured "sleep log" that conveyed their subjective impressions as to how they had slept. The correlation between objectively measured sleep characteristics and the symptoms and physical findings, respectively, resulting from whiplash injury were also examined.
RESULTS: Actigraphic monitoring did not reveal a significant group difference between whiplash-injured subjects and controls with respect to any of the sleep characteristics recorded. In self-maintained "sleep logs," however, the whiplash-injured subjects reported a significantly prolonged sleep latency and significantly impaired sleep quality compared with controls (P<.001 and P<.04, respectively). In whiplash-injured subjects, the number of arousals was positively correlated with the number of symptoms and with the number of physical signs of whiplash injury (P<.01 and P<.001, respectively). Sleep efficiency was inversely correlated with the number of injury-related findings on physical examination (P<.009).
CONCLUSION: Sleep, as monitored by actigraph in whiplash-injured subjects, was not adversely affected by whiplash injury. The subjective impressions of the subjects, as recorded in "sleep logs," suggest the opposite conclusion. A significant correlation exists between certain symptoms and signs of whiplash injury and abnormalities in given sleep characteristics as detected by actigraph.

Entities:  

Mesh:

Year:  2001        PMID: 11437895     DOI: 10.1046/j.1526-4610.2001.041006586.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

Review 1.  A review of treatment interventions in whiplash-associated disorders.

Authors:  Aris Seferiadis; Mark Rosenfeld; Ronny Gunnarsson
Journal:  Eur Spine J       Date:  2004-05-05       Impact factor: 3.134

Review 2.  Whiplash associated disorders: a review of the literature to guide patient information and advice.

Authors:  T McClune; A K Burton; G Waddell
Journal:  Emerg Med J       Date:  2002-11       Impact factor: 2.740

3.  Psychiatric Sequelae Following Whiplash Injury: A Systematic Review.

Authors:  Haidar Muhsen Al-Khazali; Håkan Ashina; Afrim Iljazi; Zainab Al-Sayegh; Richard B Lipton; Messoud Ashina; Sait Ashina; Henrik W Schytz
Journal:  Front Psychiatry       Date:  2022-04-22       Impact factor: 5.435

4.  Surgical fasciectomy of the trapezius muscle combined with neurolysis of the Spinal accessory nerve; results and long-term follow-up in 30 consecutive cases of refractory chronic whiplash syndrome.

Authors:  N Ake Nystrom; Lloyd P Champagne; Michael Freeman; Elisabet Blix
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-04-07

5.  Sleep, mood, and quality of life in patients receiving treatment for lung cancer.

Authors:  Grace E Dean; Nancy S Redeker; Ya-Jung Wang; Ann E Rogers; Suzanne S Dickerson; Lynn M Steinbrenner; Nalaka S Gooneratne
Journal:  Oncol Nurs Forum       Date:  2013-09       Impact factor: 2.172

6.  Temperament and character: prognostic factors in whiplash patients?

Authors:  Kurt Pettersson; Sven Brändström; Göran Toolanen; Christer Hildingsson; Per-Olof Nylander
Journal:  Eur Spine J       Date:  2004-03-27       Impact factor: 3.134

7.  Subgroups based on thermal and pressure pain thresholds in women with chronic whiplash display differences in clinical presentation - an explorative study.

Authors:  Björn Börsbo; Gunilla M Liedberg; Mia Wallin; Björn Gerdle
Journal:  J Pain Res       Date:  2012-11-08       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.